CBD-Intel

Regulatory trackers

US regulatory tracker: Enacted regulation of CBD January

Written by || 18th January 2022 || Regulatory trackers | Regulation and Legislation | California Colorado Connecticut Florida Georgia Illinois Massachusetts Michigan Nevada New Jersey North America North Carolina Ohio Oregon Pennsylvania South Carolina Tennessee Texas United States Utah Virginia Washington

Welcome to the CBD-Intel US enacted law regulatory tracker, updated each month. Within this interactive map gain insight into the enacted bills for 22 US states, with more state coverage coming very soon. ...

Restricted content. Do you want to read more?

Read our latest free content
How US Democrats’ cannabis reform plans ran aground despite promises
Insurance rule ‘a billion-dollar shot in the arm’ for Colombian cannabis market
Colombian insurance policy shows real intent to lead on cannabinoids
Rival bills aim to establish a pathway to the US market for ingestible CBD
CBD-Intel’s crystal ball reveals possible intoxicating prospects for the year ahead
Legal eagle Kight explains how the USPS could have modified PACT Act regulation

Featured topic

The Food and Drug Administration (FDA) rejected applications to use hemp extract as a dietary supplement.

Here are the conclusions we have attracted. CBD-Intel will continue to work on providing answers to the various questions that have arisen.

Blog | Policy and politics | US federal regulation

Sign up to our newsletter

By signing up you agree to our Terms and Conditions